Related Experiment Video
Updated: Mar 31, 2026

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
Myocardial steatosis as a possible mechanistic link between diastolic dysfunction and coronary microvascular
Janet Wei1, Michael D Nelson2, Edward W Szczepaniak2
1Barbra Streisand Women's Heart Center, Cedars-Sinai Heart Institute, Los Angeles, California; janet.wei@cshs.org.
Insights
Women with coronary microvascular dysfunction (CMD) experience heart failure with preserved ejection fraction (HFpEF). Myocardial steatosis, or heart fat, was more prevalent in these women, contributing to diastolic dysfunction.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Metabolic Heart Disease
Background:
- Coronary microvascular dysfunction (CMD) without obstructive coronary artery disease (CAD) is linked to increased heart failure with preserved ejection fraction (HFpEF) in women.
- The underlying mechanisms of HFpEF in this population remain unclear.
- Myocardial steatosis (ectopic fat in the heart muscle) is associated with diastolic dysfunction in other metabolic conditions.
Purpose of the Study:
- To investigate the prevalence of myocardial steatosis and diastolic dysfunction in women with CMD and subclinical HFpEF.
- To explore the relationship between myocardial fat content and diastolic function in this specific patient group.
Main Methods:
- Study included 13 women: 8 controls and 5 with CMD and subclinical HFpEF (elevated left ventricular end-diastolic pressure).
- Myocardial triglyceride content was measured using proton magnetic resonance spectroscopy.
- Diastolic function was assessed via magnetic resonance tissue tagging.
Main Results:
- Women with CMD exhibited significantly higher myocardial triglyceride content compared to controls (0.83% ± 0.12% vs. 0.43% ± 0.06%, P = 0.025).
- Diastolic circumferential strain rate was lower in women with CMD (168 ± 12%/s vs. 217 ± 15%/s, P = 0.012).
- Myocardial triglyceride content showed a significant inverse correlation with diastolic circumferential strain rate (r = -0.779, P = 0.002).
Conclusions:
- This proof-of-concept study suggests myocardial steatosis may be a key factor in diastolic dysfunction among women with CMD and no obstructive CAD.
- Further longitudinal research is needed to confirm these findings and evaluate targeted treatments for myocardial steatosis.
- Understanding the role of myocardial fat could lead to novel therapeutic strategies for HFpEF in women with CMD.
Abstract:
Women with coronary microvascular dysfunction (CMD) and no obstructive coronary artery disease (CAD) have increased rates of heart failure with preserved ejection fraction (HFpEF). The mechanisms of HFpEF are not well understood. Ectopic fat deposition in the myocardium, termed myocardial steatosis, is frequently associated with diastolic dysfunction in other metabolic diseases. We investigated the prevalence of myocardial steatosis and diastolic dysfunction in women with CMD and subclinical HFpEF. In 13 women, including eight reference controls and five women with CMD and evidence of subclinical HFpEF (left ventricular end-diastolic pressure >12 mmHg), we measured myocardial triglyceride content (TG) and diastolic function, by proton magnetic resonance spectroscopy and magnetic resonance tissue tagging, respectively. When compared with reference controls, women with CMD had higher myocardial TG content (0.83 ± 0.12% vs. 0.43 ± 0.06%; P = 0.025) and lower diastolic circumferential strain rate (168 ± 12 vs. 217 ± 15%/s; P = 0.012), with myocardial TG content correlating inversely with diastolic circumferential strain rate (r = -0.779; P = 0.002). This study provides proof-of-concept that myocardial steatosis may play an important mechanistic role in the development of diastolic dysfunction in women with CMD and no obstructive CAD. Detailed longitudinal studies are warranted to explore specific treatment strategies targeting myocardial steatosis and its effect on diastolic function.
More Related Videos
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Stenosis I: Introduction
Myocarditis I: Introduction